Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliers
advertisement
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
Culture Eats HACCP for Breakfast (free)
-
STEC in Focus: Navigating Risk, Regulation, and Rapid Detection
-
Accelerate Your E. coli Testing with 6 hours Results
-
Pathogen Method Validation: When Is It Necessary? When Is a Matrix Extension Needed?
-
Practical Tips for Streamlining Nucleic Acid Extraction and Molecular Workflows
-
LIMS Launchpad Webinar Series - Episode #3 - Automations and Integrations
-
From Contamination to Control: Rapid Water Testing in Action
-
The Next Step for Bioburden Testing in Water
-
A3P International Congress 2025
-
Microbiology for Non-Microbiologists STEM
